ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login


Journal: International Journal of Advanced Research (Vol.7, No. 8)

Publication Date:

Authors : ; ;

Page : 631-637

Keywords : SandhigataVata Osteoarthritis AjmodadiVatak.;

Source : Downloadexternal Find it from : Google Scholarexternal


Ayurveda, the holistic science an upveda of Atharva Veda was incepted by Brahma. The aim of Ayurveda is to maintain the state of good health of healthy person and render cure to the suffering. A healthy life and higher longevity are always desirable. During different stages of human life disease prevalence is common due to genetic, infection, infestations, systemic, environmental, age related issues and so on. Health and disease are two opposite diversions of life. The human body is so peculiar, it decays in every moment. As per ayurveda the life span (ayu) is devided into three parts viz. Balyavastha, ,Maddhyavastha, Vriddhavastha1. In Vriddhavastha due to Physiological and Pathological changes gradual deterioration, decreasing ability and inactivity occurs. Ayurveda states that in Vriddhavastha all dhatus undergo kshaya leading to Vataprakopa and making individual prone to some diseases. Among them Sandhigatavata is very common. According to world health organization (WHO) Sandhigatavata (Osteoarthritis) is the second commonest musculoskeletal problem in the world population (30%) after back pain (50%). It is occurring in about 20% the population as a whole and in 50% of those above the age of 60 yrs. Disease starts between the age of 45-50 yrs. It is the common cause of disability in an elderly population throughout the world. Considering this and keeping in view the prevalence of this disease. I have been employed through this Clinical Study. I have done Clinical trial work in the management of Sandhigatavata with AjmodadiVatak (Herbal formulation) and compared with control drug Piroxicam. In this study total 80 patients were selected, 50 patients were treated with trial drug AjmodadiVatak and 30 patients were treated with control drug Piroxicam. Study reveals AjmodadiVatak is effective in SandhigataVata.

Last modified: 2019-09-16 18:12:03